SEATTLE, Nov. 4, 2013 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) today
announced that it will conduct a conference call on Tuesday, November
12, 2013 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss its
third quarter 2013 financial results and provide a review of its
pipeline of products in development.
To participate in the call by telephone, please dial (877) 280-7291
(United States) or (707) 287-9361 (International). In addition, the
call will be webcast live and can be accessed on the "Events" page of
the "News & Events" section of Oncothyreon's website at www.oncothyreon.com. An archive of the webcast will be available after completion of the
discussion and will be posted on the Oncothyreon website.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE: Oncothyreon Inc.
For further information:
Investor and Media Relations Contact:
2601 Fourth Avenue, Suite 500
Seattle, WA 98121
Tel: (206) 801-2100
Fax: (206) 801-2101